Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer. | Front Oncol | 2022 | 35480096 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Nucleotide Excision Repair. | Front Cell Dev Biol | 2022 | 35465333 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair. | Front Oncol | 2022 | 35463312 | PubTator, text mining | PubMed |
| Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy. | J Med Imaging Radiat Oncol | 2022 | 35460184 | PubTator, text mining | PubMed |
| Impact of Nano- and Micro-Sized Chromium(III) Particles on Cytotoxicity and Gene Expression Profiles Related to Genomic Stability in Human Keratinocytes and Alveolar Epithelial Cells. | Nanomaterials (Basel) | 2022 | 35458002 | PubTator, text mining | PubMed |
| Genome Integrity and Neurological Disease. | Int J Mol Sci | 2022 | 35456958 | PubTator, text mining | PubMed |
| Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. | Cancers (Basel) | 2022 | 35454946 | PubTator, text mining | PubMed |
| Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples. | Cancers (Basel) | 2022 | 35454858 | PubTator, text mining | PubMed |
| Regulation of Mus81-Eme1 structure-specific endonuclease by Eme1 SUMO-binding and Rad3ATR kinase is essential in the absence of Rqh1BLM helicase. | PLoS Genet | 2022 | 35452455 | PubTator, text mining | PubMed |
| Generation of double Holliday junction DNAs and their dissolution/resolution within a chromatin context. | Proc Natl Acad Sci U S A | 2022 | 35452329 | PubTator, text mining | PubMed |
| CHD4 is recruited by GATA4 and NKX2-5 to repress noncardiac gene programs in the developing heart. | Genes Dev | 2022 | 35450884 | PubTator, text mining | PubMed |
| Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. | Front Pharmacol | 2022 | 35444536 | PubTator, text mining | PubMed |
| Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease. | Front Cell Neurosci | 2022 | 35444517 | PubTator, text mining | PubMed |
| Integrative Analyses of Circulating mRNA and lncRNA Expression Profile in Plasma of Lung Cancer Patients. | Front Oncol | 2022 | 35433477 | PubTator, text mining | PubMed |
| The Role of DNA Repair in Immunological Diversity: From Molecular Mechanisms to Clinical Ramifications. | Front Immunol | 2022 | 35432317 | PubTator, text mining | PubMed |
| Facial skin ageing: Key concepts and overview of processes. | Int J Cosmet Sci | 2022 | 35426152 | PubTator, text mining | PubMed |
| Mechanisms of Chemotherapy-Induced Neurotoxicity. | Front Pharmacol | 2022 | 35418856 | PubTator, text mining | PubMed |
| Holliday junction resolution by At-HIGLE: an SLX1 lineage endonuclease from Arabidopsis thaliana with a novel in-built regulatory mechanism. | Nucleic Acids Res | 2022 | 35412622 | PubTator, text mining | PubMed |
| The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells. | Int J Mol Sci | 2022 | 35408996 | PubTator, text mining | PubMed |
| Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside. | Int J Mol Sci | 2022 | 35408920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=31